Basic Information
Basic information for LINC00662-209-15aa
Peptide Name LINC00662-209-15aa
Genome Position chr19:27793026-27793070[-]
Species Human
Peptide Sequence MGRAEGPRVKVPSPW
Peptide Length 15
Unique No (LINC00662-202-15aa,LINC00662-203-15aa,LINC00662-204-15aa,LINC00662-207-15aa,LINC00662-224-15aa,LINC00662-225-15aa-2,LINC00662-226-15aa,LINC00662-231-15aa,LINC00662-232-15aa,LINC00662-237-15aa,LINC00662-240-15aa-1,LINC00662-242-15aa,LINC00662-243-15aa-1,LINC00662-244-15aa,LINC00662-245-15aa,LINC00662-247-15aa,LINC00662-248-15aa,LINC00662-249-15aa,LINC00662-251-15aa,LINC00662-252-15aa,LINC00662-255-15aa,LINC00662-257-15aa,LINC00662-259-15aa,LINC00662-263-15aa,LINC00662-265-15aa,LINC00662-268-15aa,LINC00662-277-15aa)
Grand Average of Hydropathicity -0.7733
Relative Molecular Mass 1919.16
Experimental Evidences 3:lncORF,m6A,ribo
lncRNA ID/Name ENSG00000261824;LINC00662
Transcript ID/Name ENST00000591458;LINC00662-209
Transcript Length 578
Coding Ability 0.1436
DNA Sequence Corresponding to Peptide ATGGGCAGGGCCGAAGGTCCGCGTGTAAAAGTACCCAGTCCCTGG
Experimental Evidences
   lncORF
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :